$NHI
NATIONAL HEALTH INVESTORS INC

2021 Q1 Form 10-Q Financial Statement

#000087786021000036 Filed on May 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q4 2020 Q1
Revenue $80.89M $81.26M $83.08M
YoY Change -2.64% -1.14% 9.16%
Cost Of Revenue $2.160M $2.460M $1.550M
YoY Change 39.35% 54.72% 42.2%
Gross Profit $78.72M $78.78M $81.55M
YoY Change -3.47% -2.26% 8.7%
Gross Profit Margin 97.32% 96.95% 98.16%
Selling, General & Admin $8.350M $3.580M $4.890M
YoY Change 70.76% -6.28% 1.24%
% of Gross Profit 10.61% 4.54% 6.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $20.81M $21.10M $20.44M
YoY Change 1.78% 7.65% 10.56%
% of Gross Profit 26.43% 26.78% 25.07%
Operating Expenses $44.24M $24.62M $42.58M
YoY Change 3.91% 4.72% 5.32%
Operating Profit $34.48M $54.16M $38.97M
YoY Change -11.53% -5.13% 9.23%
Interest Expense $12.97M -$13.09M $14.14M
YoY Change -8.25% -8.46% 4.6%
% of Operating Profit 37.63% -24.17% 36.28%
Other Income/Expense, Net
YoY Change
Pretax Income $35.38M $37.16M $61.06M
YoY Change -42.06% -11.61% 71.13%
Income Tax
% Of Pretax Income
Net Earnings $35.33M $37.14M $61.02M
YoY Change -42.1% -11.66% 71.03%
Net Earnings / Revenue 43.68% 45.71% 73.45%
Basic Earnings Per Share $0.78 $0.83 $1.37
Diluted Earnings Per Share $0.78 $0.83 $1.37
COMMON SHARES
Basic Shares Outstanding 45.31M shares 44.86M shares 44.61M shares
Diluted Shares Outstanding 45.36M shares 44.86M shares 44.62M shares

Balance Sheet

Concept 2021 Q1 2020 Q4 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $113.4M $43.30M $46.00M
YoY Change 146.52% 732.69% 784.62%
Cash & Equivalents $113.4M $43.34M $46.05M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $2.594M $3.600M
Other Receivables $95.70M $85.70M
Total Short-Term Assets $211.8M $141.6M $135.3M
YoY Change 56.54% 49.84% 62.62%
LONG-TERM ASSETS
Property, Plant & Equipment $2.648B $2.667B $2.693B
YoY Change -1.68% 4.18% 10.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.300M $2.250M $433.0K
YoY Change 662.12%
Other Assets $2.900M $3.000M $33.80M
YoY Change -91.42% -89.62% 139.72%
Total Long-Term Assets $2.971B $2.979B $3.033B
YoY Change -2.01% 1.06% 11.36%
TOTAL ASSETS
Total Short-Term Assets $211.8M $141.6M $135.3M
Total Long-Term Assets $2.971B $2.979B $3.033B
Total Assets $3.183B $3.120B $3.168B
YoY Change 0.49% 2.57% 12.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.70M $25.20M $34.70M
YoY Change -31.7% -4.18% 62.15%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $84.90M $85.70M $94.60M
YoY Change -10.25% 2.27% 20.36%
LONG-TERM LIABILITIES
Long-Term Debt $1.525B $1.499B $1.549B
YoY Change -1.56% 4.08% 20.33%
Other Long-Term Liabilities $11.00M $12.60M $17.40M
YoY Change -36.78% -36.36% -29.27%
Total Long-Term Liabilities $1.536B $1.512B $1.566B
YoY Change -1.95% 3.53% 19.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $84.90M $85.70M $94.60M
Total Long-Term Liabilities $1.536B $1.512B $1.566B
Total Liabilities $1.621B $1.598B $1.661B
YoY Change -2.43% 3.47% 19.46%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $1.595B $1.541B $1.505B
YoY Change 5.93% 2.32% 6.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.552B $1.512B $1.496B
YoY Change
Total Liabilities & Shareholders Equity $3.183B $3.120B $3.168B
YoY Change 0.49% 2.57% 12.88%

Cashflow Statement

Concept 2021 Q1 2020 Q4 2020 Q1
OPERATING ACTIVITIES
Net Income $35.33M $37.14M $61.02M
YoY Change -42.1% -11.66% 71.03%
Depreciation, Depletion And Amortization $20.81M $21.10M $20.44M
YoY Change 1.78% 7.65% 10.56%
Cash From Operating Activities $56.91M $55.60M $57.08M
YoY Change -0.3% -1.07% -22.69%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 -$80.30M
YoY Change -100.0% -100.0% 60.28%
Acquisitions
YoY Change
Other Investing Activities -$9.100M -$6.300M $29.30M
YoY Change -131.06% -77.17% -296.64%
Cash From Investing Activities -$9.133M -$6.300M -$51.02M
YoY Change -82.1% -83.24% -21.56%
FINANCING ACTIVITIES
Cash Dividend Paid $49.82M $46.82M
YoY Change 6.41% 9.64%
Common Stock Issuance & Retirement, Net $47.95M -$87.00K
YoY Change -55216.09% -100.24%
Debt Paid & Issued, Net $100.1M $304.0K
YoY Change 32825.66% 2.7%
Cash From Financing Activities $22.11M -54.10M $58.08M
YoY Change -61.94% 181.77% -1940.43%
NET CHANGE
Cash From Operating Activities $56.91M 55.60M $57.08M
Cash From Investing Activities -$9.133M -6.300M -$51.02M
Cash From Financing Activities $22.11M -54.10M $58.08M
Net Change In Cash $69.89M -4.800M $64.15M
YoY Change 8.94% 700.0% 1036.99%
FREE CASH FLOW
Cash From Operating Activities $56.91M $55.60M $57.08M
Capital Expenditures $0.00 $0.00 -$80.30M
Free Cash Flow $56.91M $55.60M $137.4M
YoY Change -58.57% -16.01% 10.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000877860
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45185992 shares
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45850599 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45850599 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45185992 shares
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.1025
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.1025
CY2019Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.10
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.10
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-10822
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
45850599 shares
CY2021Q1 us-gaap Land
Land
220361000 USD
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
National Health Investors Inc
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
62-1470956
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
222 Robert Rose Drive
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Murfreesboro
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37129
CY2021Q1 dei City Area Code
CityAreaCode
(615)
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
890-9100
CY2021Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2021Q1 dei Trading Symbol
TradingSymbol
NHI
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q4 us-gaap Land
Land
220361000 USD
CY2021Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
3042763000 USD
CY2020Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
3041616000 USD
CY2021Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
3131000 USD
CY2020Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
3093000 USD
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3266255000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3265070000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
618299000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
597638000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2647956000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2667432000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4856000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4946000 USD
CY2021Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
301318000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
292427000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
113375000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43344000 USD
CY2021Q1 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
98354000 USD
CY2020Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
95703000 USD
CY2021Q1 us-gaap Other Assets
OtherAssets
22270000 USD
CY2021Q1 us-gaap Other Assets
OtherAssets
22270000 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
21583000 USD
CY2021Q1 us-gaap Assets
Assets
3183273000 USD
CY2020Q4 us-gaap Assets
Assets
3120489000 USD
CY2021Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1524725000 USD
CY2020Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1499285000 USD
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
23673000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
25189000 USD
CY2021Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
50550000 USD
CY2020Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
49818000 USD
CY2021Q1 us-gaap Security Deposit Liability
SecurityDepositLiability
10638000 USD
CY2020Q4 us-gaap Security Deposit Liability
SecurityDepositLiability
10638000 USD
CY2021Q1 us-gaap Deferred Revenue
DeferredRevenue
10972000 USD
CY2020Q4 us-gaap Deferred Revenue
DeferredRevenue
12614000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
1620558000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
1597544000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
459000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
452000 USD
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1594336000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1540946000 USD
CY2021Q1 us-gaap Cumulative Earnings Deficit
CumulativeEarningsDeficit
-37233000 USD
CY2020Q4 us-gaap Cumulative Earnings Deficit
CumulativeEarningsDeficit
-22015000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5377000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7149000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1552185000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1512234000 USD
CY2021Q1 us-gaap Minority Interest
MinorityInterest
10530000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
10711000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1562715000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1522945000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3183273000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3120489000 USD
CY2021Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
74749000 USD
CY2020Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
76527000 USD
CY2021Q1 us-gaap Interest Income Operating
InterestIncomeOperating
6136000 USD
CY2020Q1 us-gaap Interest Income Operating
InterestIncomeOperating
6549000 USD
CY2021Q1 us-gaap Revenues
Revenues
80885000 USD
CY2020Q1 us-gaap Revenues
Revenues
83076000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
20806000 USD
CY2020Q1 us-gaap Depreciation
Depreciation
20443000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
12973000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
14140000 USD
CY2021Q1 us-gaap Legal Fees
LegalFees
130000 USD
CY2020Q1 us-gaap Legal Fees
LegalFees
334000 USD
CY2021Q1 nhi Franchise Excise And Other Taxes
FranchiseExciseAndOtherTaxes
233000 USD
CY2020Q1 nhi Franchise Excise And Other Taxes
FranchiseExciseAndOtherTaxes
243000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7989000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4311000 USD
CY2021Q1 nhi Lessor Property Costs Paid From Tenant Escrow
LessorPropertyCostsPaidFromTenantEscrow
2161000 USD
CY2020Q1 nhi Lessor Property Costs Paid From Tenant Escrow
LessorPropertyCostsPaidFromTenantEscrow
1553000 USD
CY2021Q1 nhi Loanand Lease Lossesand Recoveries Net
LoanandLeaseLossesandRecoveriesNet
-50000 USD
CY2020Q1 nhi Loanand Lease Lossesand Recoveries Net
LoanandLeaseLossesandRecoveriesNet
1555000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
44242000 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
42579000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-808000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-442000 USD
CY2021Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 USD
CY2020Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
21007000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-6000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
35384000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
61062000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
52000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
39000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
35332000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
61023000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45305087 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44613593 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45357773 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44618139 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.37
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.37
CY2021Q1 us-gaap Profit Loss
ProfitLoss
35384000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
61062000 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-9191000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-1778000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-492000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1772000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8699000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
37156000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
52363000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
52000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
39000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
37104000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
52324000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
35384000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
61062000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
20806000 USD
CY2020Q1 us-gaap Depreciation
Depreciation
20443000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1192000 USD
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1173000 USD
CY2021Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
131000 USD
CY2020Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
129000 USD
CY2021Q1 us-gaap Amortization Of Lease Incentives
AmortizationOfLeaseIncentives
260000 USD
CY2020Q1 us-gaap Amortization Of Lease Incentives
AmortizationOfLeaseIncentives
236000 USD
CY2021Q1 us-gaap Straight Line Rent
StraightLineRent
4241000 USD
CY2020Q1 us-gaap Straight Line Rent
StraightLineRent
5177000 USD
CY2021Q1 us-gaap Other Noncash Income
OtherNoncashIncome
700000 USD
CY2020Q1 us-gaap Other Noncash Income
OtherNoncashIncome
888000 USD
CY2021Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 USD
CY2020Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
21007000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-808000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-442000 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-451000 USD
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q1 nhi Loanand Lease Lossesand Recoveries Net
LoanandLeaseLossesandRecoveriesNet
-50000 USD
CY2020Q1 nhi Loanand Lease Lossesand Recoveries Net
LoanandLeaseLossesandRecoveriesNet
1555000 USD
CY2021Q1 nhi Paymentof Tenant Lease Incentives
PaymentofTenantLeaseIncentives
-1042000 USD
CY2020Q1 nhi Paymentof Tenant Lease Incentives
PaymentofTenantLeaseIncentives
0 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5446000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1845000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
484000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
357000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-735000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1497000 USD
CY2021Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-52000 USD
CY2020Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-619000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
56912000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
57082000 USD
CY2021Q1 us-gaap Payments To Acquire Mortgage Notes Receivable
PaymentsToAcquireMortgageNotesReceivable
8412000 USD
CY2020Q1 us-gaap Payments To Acquire Mortgage Notes Receivable
PaymentsToAcquireMortgageNotesReceivable
20298000 USD
CY2021Q1 us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
442000 USD
CY2020Q1 us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
14288000 USD
CY2021Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
0 USD
CY2020Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
80335000 USD
CY2021Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
8000 USD
CY2020Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
0 USD
CY2021Q1 nhi Payments To Renovate Real Estate
PaymentsToRenovateRealEstate
1443000 USD
CY2020Q1 nhi Payments To Renovate Real Estate
PaymentsToRenovateRealEstate
3057000 USD
CY2021Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 USD
CY2020Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
875000 USD
CY2021Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
288000 USD
CY2020Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0 USD
CY2021Q1 us-gaap Proceeds From Sale Of Wholly Owned Real Estate And Real Estate Acquired In Settlement Of Loans
ProceedsFromSaleOfWhollyOwnedRealEstateAndRealEstateAcquiredInSettlementOfLoans
0 USD
CY2020Q1 us-gaap Proceeds From Sale Of Wholly Owned Real Estate And Real Estate Acquired In Settlement Of Loans
ProceedsFromSaleOfWhollyOwnedRealEstateAndRealEstateAcquiredInSettlementOfLoans
39260000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9133000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51017000 USD
CY2021Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
30000000 USD
CY2020Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
125000000 USD
CY2021Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
298000000 USD
CY2020Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
17000000 USD
CY2021Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
100094000 USD
CY2020Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
304000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
396784000 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 USD
CY2021Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4459000 USD
CY2020Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2021Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
258000 USD
CY2020Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
16000 USD
CY2021Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 USD
CY2020Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
13000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2705000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
47951000 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-87000 USD
CY2021Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
49818000 USD
CY2020Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
46817000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22106000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
58084000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
69885000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
64149000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46343000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15669000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
116228000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79818000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
9674000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
12954000 USD
CY2021Q1 nhi Additions Through Settlement Of Mortgage Note
AdditionsThroughSettlementOfMortgageNote
0 USD
CY2020Q1 nhi Additions Through Settlement Of Mortgage Note
AdditionsThroughSettlementOfMortgageNote
59350000 USD
CY2021Q1 nhi Increase In Mortgage Note Receivable From Sale Of Real Estate
IncreaseInMortgageNoteReceivableFromSaleOfRealEstate
0 USD
CY2020Q1 nhi Increase In Mortgage Note Receivable From Sale Of Real Estate
IncreaseInMortgageNoteReceivableFromSaleOfRealEstate
4000000 USD
CY2021Q1 nhi Changein Accounts Payable Investmentsin Real Estate Construction
ChangeinAccountsPayableInvestmentsinRealEstateConstruction
-112000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5446000 USD
CY2020Q1 nhi Changein Accounts Payable Investmentsin Real Estate Construction
ChangeinAccountsPayableInvestmentsinRealEstateConstruction
-234000 USD
CY2021Q1 nhi Change In Accounts Payable Related To Distributions To Noncontrolling Interests
ChangeInAccountsPayableRelatedToDistributionsToNoncontrollingInterests
-25000 USD
CY2020Q1 nhi Change In Accounts Payable Related To Distributions To Noncontrolling Interests
ChangeInAccountsPayableRelatedToDistributionsToNoncontrollingInterests
0 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1522945000 USD
CY2020 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
0 USD
CY2021Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
233000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
37156000 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
47951000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
50550000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1562715000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1498252000 USD
CY2020Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
10791000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
52363000 USD
CY2020Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-85000 USD
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2705000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1845000 USD
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
49226000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1506993000 USD
CY2021Q1 nhi Real Estate Investment Property Portfolio Assets
RealEstateInvestmentPropertyPortfolioAssets
3300000000 USD
CY2021Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
228 properties
CY2021Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
34
CY2021Q1 nhi Number Of Lessees
NumberOfLessees
34
CY2021Q1 nhi Number Of Health Care Properties Related To Mortgage Notes Receivables
NumberOfHealthCarePropertiesRelatedToMortgageNotesReceivables
14 beds_or_units
CY2021Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
306200000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4900000 USD
CY2021Q1 nhi Variable Interest Entity Number Of Entities Not Primary Beneficiary
VariableInterestEntityNumberOfEntitiesNotPrimaryBeneficiary
7 properties
CY2021Q1 us-gaap Cash
Cash
113375000 USD
CY2020Q1 us-gaap Cash
Cash
46049000 USD
CY2021Q1 us-gaap Restricted Cash
RestrictedCash
2853000 USD
CY2020Q1 us-gaap Restricted Cash
RestrictedCash
33769000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
116228000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79818000 USD
CY2021Q1 nhi Nonportfolio Assets Original Cost
NonportfolioAssetsOriginalCost
2500000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4900000 USD
CY2021Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
3263713000 USD
CY2021Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
306174000 USD
CY2021Q1 us-gaap Revenues
Revenues
80885000 USD
CY2020Q1 us-gaap Revenues
Revenues
83076000 USD
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
215167000 USD
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
287817000 USD
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
283511000 USD
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
277004000 USD
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
273507000 USD
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
277816000 USD
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
1158838000 USD
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2773660000 USD
CY2021Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
74749000 USD
CY2021Q1 us-gaap Amortization Of Lease Incentives
AmortizationOfLeaseIncentives
260000 USD
CY2020Q1 us-gaap Amortization Of Lease Incentives
AmortizationOfLeaseIncentives
236000 USD
CY2020Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
76527000 USD
CY2021Q1 nhi Number Of Health Care Properties Related To Mortgage Notes Receivables
NumberOfHealthCarePropertiesRelatedToMortgageNotesReceivables
14 properties
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4900000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4856000 USD
CY2021Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
301318000 USD
CY2021Q1 nhi Probability Of Default Increase Current Conditions Adjustment
ProbabilityOfDefaultIncreaseCurrentConditionsAdjustment
0.20
CY2021Q1 nhi Probability Of Default Increase Current Conditions Adjustment
ProbabilityOfDefaultIncreaseCurrentConditionsAdjustment
0.20
CY2021Q1 nhi Estimated Credit Losses Current Conditions Adjustment Combined
EstimatedCreditLossesCurrentConditionsAdjustmentCombined
0.44
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4946000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-90000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4856000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-800000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-400000 USD
CY2021Q1 us-gaap Equity Method Investments
EquityMethodInvestments
3300000 USD
CY2021Q1 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
16700000 USD
CY2021Q1 us-gaap Line Of Credit
LineOfCredit
30000000 USD
CY2020Q4 us-gaap Line Of Credit
LineOfCredit
298000000 USD
CY2021Q1 us-gaap Convertible Debt
ConvertibleDebt
60000000 USD
CY2020Q4 us-gaap Convertible Debt
ConvertibleDebt
60000000 USD
CY2021Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
7373000 USD
CY2020Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
4069000 USD
CY2021Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1524725000 USD
CY2020Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1499285000 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
60277000 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
280389000 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
475408000 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
75425000 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
143761000 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
0 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive
496838000 USD
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1532098000 USD
CY2021Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
7373000 USD
CY2021Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1524725000 USD
CY2021Q1 nhi Credit Facility Current Revolving Borrowing Capacity
CreditFacilityCurrentRevolvingBorrowingCapacity
550000000.0 USD
CY2021Q1 us-gaap Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
0.0020
CY2021Q1 nhi Debt Instrument Variable Rate Basis Minimum
DebtInstrumentVariableRateBasisMinimum
11
CY2020Q4 nhi Debt Instrument Variable Rate Basis Minimum
DebtInstrumentVariableRateBasisMinimum
14
CY2021Q1 us-gaap Unsecured Debt
UnsecuredDebt
400000000 USD
CY2021Q1 nhi Debt Leverage Limit Coupon Change Trigger
DebtLeverageLimitCouponChangeTrigger
0.50
CY2021Q1 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
5400000 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-7100000 USD
CY2021Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
10452000 USD
CY2020Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
13003000 USD
CY2021Q1 us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
1778000 USD
CY2020Q1 us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
492000 USD
CY2021Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
16000 USD
CY2020Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
98000 USD
CY2021Q1 nhi Amortization Of Financing Costs Exclusive Of Amounts Written Off
AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff
759000 USD
CY2020Q1 nhi Amortization Of Financing Costs Exclusive Of Amounts Written Off
AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff
743000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
12973000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
14140000 USD
CY2021Q1 us-gaap Loans And Leases Receivable Commitments Fixed Rates
LoansAndLeasesReceivableCommitmentsFixedRates
285900000 USD
CY2021Q1 nhi Notes Receivable Funding Commitment
NotesReceivableFundingCommitment
62395000 USD
CY2021Q1 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
40000 USD
CY2021Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
310000 USD
CY2021Q1 nhi Maximum Commitment For All Active Development Projects
MaximumCommitmentForAllActiveDevelopmentProjects
28395000 USD
CY2021Q1 us-gaap Development In Process
DevelopmentInProcess
23445000 USD
CY2021Q1 nhi Remaining Unfunded Development Commitment
RemainingUnfundedDevelopmentCommitment
4950000 USD
CY2021Q1 nhi Contingent Funding Commitment
ContingentFundingCommitment
31900000 USD
CY2021Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
661951 shares
CY2021Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
73.62
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
48000000.0 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5446000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1845000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.067
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.051
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.481
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.168
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y10M24D
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y10M24D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0033
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0131
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1004014 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
74.35
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
584500 shares
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
90.79
CY2020Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
512509 shares
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
72.98
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
8000 shares
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
88.08
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1068005 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
83.90
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
600327 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
81.22
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1033838 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
83.54
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
652000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
69.20
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
20000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
60.52
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1665838 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
78.20
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10M17D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1180824 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
79.31
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y6M29D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2800000 USD
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1700000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
200000 USD
CY2021Q1 nhi Aggregate Intrinsic Value Per Share Options Exercised
AggregateIntrinsicValuePerShareOptionsExercised
9.27
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
8100000 USD
CY2020Q1 nhi Aggregate Intrinsic Value Per Share Options Exercised
AggregateIntrinsicValuePerShareOptionsExercised
15.84
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4800000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
35332000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
61023000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45305087 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44613593 shares
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
45305087 shares
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
44613593 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
10873 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4546 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
41813 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45357773 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44618139 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.37
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.37
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
216762 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
305862 shares
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.1025
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.1025
CY2021Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
3263713000 USD
CY2021Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
306174000 USD
CY2021Q1 us-gaap Revenues
Revenues
80885000 USD
CY2020Q1 us-gaap Revenues
Revenues
83076000 USD
CY2021Q1 us-gaap Revenues
Revenues
80885000 USD
CY2020Q1 us-gaap Revenues
Revenues
83076000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.481

Files In Submission

Name View Source Status
0000877860-21-000036-index-headers.html Edgar Link pending
0000877860-21-000036-index.html Edgar Link pending
0000877860-21-000036.txt Edgar Link pending
0000877860-21-000036-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nhi-20210331.htm Edgar Link pending
nhi-20210331.xsd Edgar Link pending
nhi-20210331_cal.xml Edgar Link unprocessable
nhi-20210331_def.xml Edgar Link unprocessable
nhi-20210331_htm.xml Edgar Link completed
nhi-20210331_lab.xml Edgar Link unprocessable
nhi-20210331_pre.xml Edgar Link unprocessable
nhi-3312021x10qex311.htm Edgar Link pending
nhi-3312021x10qex312.htm Edgar Link pending
nhi-3312021x10qex32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending